We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
OncoSil Medical Ltd | ASX:OSLO | Australian Stock Exchange | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.001 | 0.001 | 0.002 | 0.00 | 00:00:00 |
DNO International ASA (DNO.OS) Thursday said an ongoing arbitration process between it and an unnamed third party about certain Kurdish oil assets are not a part of the suspension period in Kurdistan.
"There has been no formal statement of claim specifying the damages requested in the arbitration to date. During our ongoing discussions with the Kurdish Regional Government, we have understood that the arbitration is not part of the present suspension period in Kurdistan, which DNO is working to resolve as soon as possible," the company said in a statement.
DNO said the proceedings are confidential and will not divulge the identity of the third party whose claims to Kurdish interests it has rejected.
Earlier this month, KRG suspended DNO's oil operations and exports in Kurdistan on the basis that misleading and incomplete publications by the Oslo Stock Exchange relating to a DNO share sale caused unjustifiable and incalculable harm to the KRG. It said at the time that DNO had six weeks to remedy damage done to the KRG's reputation, sort out its internal issues with the stock exchange and "any other disputes that they may have with any other third parties with respect to any claims related to the production-sharing contracts." Market watchers understood that to mean DNO might have to resolve its ongoing arbitration proceedings more quickly.
Web site: www.dno.no
-By Elizabeth Adams, Dow Jones Newswires; +44 (0) 20 7842 9386; elizabeth.adams@dowjones.com
1 Year OncoSil Medical Chart |
1 Month OncoSil Medical Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions